Logo
x

Search

Subscribe Now

Worldwide Rights

ProQR Signs Exclusive Worldwide License Agreement with Ionis for IONIS-RHO-2.5 Candidate (now QR-1123)

ProQR Signs Exclusive Worldwide License Agreement with Ionis for IONIS-RHO-2.5 Candidate (now QR-1123)

  • October 30, 2018
Mylan Discloses its Previous Acquisition of Worldwide Rights to Commercialize Novartis' Products for $463M

Mylan Discloses its Previous Acquisition of Worldwide Rights to Commercialize Novartis' Products for $463M

  • September 7, 2018
Pernix Therapeutics Buys Orexigen's Contrave for $73.5Mn

Pernix Therapeutics Buys Orexigen's Contrave for $73.5Mn

  • July 30, 2018
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.